233 related articles for article (PubMed ID: 22493517)
1. Expansion of somatically reverted memory CD8+ T cells in patients with X-linked lymphoproliferative disease caused by selective pressure from Epstein-Barr virus.
Palendira U; Low C; Bell AI; Ma CS; Abbott RJ; Phan TG; Riminton DS; Choo S; Smart JM; Lougaris V; Giliani S; Buckley RH; Grimbacher B; Alvaro F; Klion AD; Nichols KE; Adelstein S; Rickinson AB; Tangye SG
J Exp Med; 2012 May; 209(5):913-24. PubMed ID: 22493517
[TBL] [Abstract][Full Text] [Related]
2. Molecular pathogenesis of EBV susceptibility in XLP as revealed by analysis of female carriers with heterozygous expression of SAP.
Palendira U; Low C; Chan A; Hislop AD; Ho E; Phan TG; Deenick E; Cook MC; Riminton DS; Choo S; Loh R; Alvaro F; Booth C; Gaspar HB; Moretta A; Khanna R; Rickinson AB; Tangye SG
PLoS Biol; 2011 Nov; 9(11):e1001187. PubMed ID: 22069374
[TBL] [Abstract][Full Text] [Related]
3. Impaired Epstein-Barr virus-specific CD8+ T-cell function in X-linked lymphoproliferative disease is restricted to SLAM family-positive B-cell targets.
Hislop AD; Palendira U; Leese AM; Arkwright PD; Rohrlich PS; Tangye SG; Gaspar HB; Lankester AC; Moretta A; Rickinson AB
Blood; 2010 Oct; 116(17):3249-57. PubMed ID: 20644117
[TBL] [Abstract][Full Text] [Related]
4. Hypogammaglobulinemia and exacerbated CD8 T-cell-mediated immunopathology in SAP-deficient mice with chronic LCMV infection mimics human XLP disease.
Crotty S; McCausland MM; Aubert RD; Wherry EJ; Ahmed R
Blood; 2006 Nov; 108(9):3085-93. PubMed ID: 16788096
[TBL] [Abstract][Full Text] [Related]
5. Early and rapid detection of X-linked lymphoproliferative syndrome with SH2D1A mutations by flow cytometry.
Zhao M; Kanegane H; Kobayashi C; Nakazawa Y; Ishii E; Kasai M; Terui K; Gocho Y; Imai K; Kiyasu J; Nonoyama S; Miyawaki T
Cytometry B Clin Cytom; 2011 Jan; 80(1):8-13. PubMed ID: 20632414
[TBL] [Abstract][Full Text] [Related]
6. XLP: clinical features and molecular etiology due to mutations in SH2D1A encoding SAP.
Tangye SG
J Clin Immunol; 2014 Oct; 34(7):772-9. PubMed ID: 25085526
[TBL] [Abstract][Full Text] [Related]
7. SAP controls the cytolytic activity of CD8+ T cells against EBV-infected cells.
Dupré L; Andolfi G; Tangye SG; Clementi R; Locatelli F; Aricò M; Aiuti A; Roncarolo MG
Blood; 2005 Jun; 105(11):4383-9. PubMed ID: 15677558
[TBL] [Abstract][Full Text] [Related]
8. [Two families of X-linked lymphoproliferative disease type 1 characterized by agammaglobulinemia].
Li WY; Chen JS; Zhao Q; Dai RX; Wang YP; Zhao HY; Chen XM; Xue XH; Sun XY; Tang XM; Zhang Y; Ding Y; Zhao XD; Zhang ZY
Zhonghua Er Ke Za Zhi; 2017 May; 55(5):377-382. PubMed ID: 28482391
[No Abstract] [Full Text] [Related]
9. SAP mediates specific cytotoxic T-cell functions in X-linked lymphoproliferative disease.
Sharifi R; Sinclair JC; Gilmour KC; Arkwright PD; Kinnon C; Thrasher AJ; Gaspar HB
Blood; 2004 May; 103(10):3821-7. PubMed ID: 14726378
[TBL] [Abstract][Full Text] [Related]
10. Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.
Sumegi J; Huang D; Lanyi A; Davis JD; Seemayer TA; Maeda A; Klein G; Seri M; Wakiguchi H; Purtilo DT; Gross TG
Blood; 2000 Nov; 96(9):3118-25. PubMed ID: 11049992
[TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus LMP1 inhibits the expression of SAP gene and upregulates Th1 cytokines in the pathogenesis of hemophagocytic syndrome.
Chuang HC; Lay JD; Hsieh WC; Wang HC; Chang Y; Chuang SE; Su IJ
Blood; 2005 Nov; 106(9):3090-6. PubMed ID: 16002423
[TBL] [Abstract][Full Text] [Related]
12. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection.
Shinozaki K; Kanegane H; Matsukura H; Sumazaki R; Tsuchida M; Makita M; Kimoto Y; Kanai R; Tsumura K; Kondoh T; Moriuchi H; Miyawaki T
Int Immunol; 2002 Oct; 14(10):1215-23. PubMed ID: 12356686
[TBL] [Abstract][Full Text] [Related]
13. Factors involved in the generation of memory CD8+ T cells in patients with X-linked lymphoproliferative disease (XLP).
Belmonte L; Parodi C; Baré P; Malbrán A; Ruibal-Ares B; de Bracco MM
Clin Exp Immunol; 2007 Mar; 147(3):456-64. PubMed ID: 17302894
[TBL] [Abstract][Full Text] [Related]
14. [X-linked lymphoproliferative syndrome, EBV virus infection and defects in cytotoxicity lymphocyte regulation].
Malbrán A; Belmonte L; Ruibal-Ares B; Baré P; Bracco MM
Medicina (B Aires); 2003; 63(1):70-6. PubMed ID: 12673966
[TBL] [Abstract][Full Text] [Related]
15. X-linked lymphoproliferative syndromes and related autosomal recessive disorders.
Veillette A; Pérez-Quintero LA; Latour S
Curr Opin Allergy Clin Immunol; 2013 Dec; 13(6):614-22. PubMed ID: 24113228
[TBL] [Abstract][Full Text] [Related]
16. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
Front Pediatr; 2019; 7():183. PubMed ID: 31231620
[TBL] [Abstract][Full Text] [Related]
17. X-linked lymphoproliferative disease is caused by deficiency of a novel SH2 domain-containing signal transduction adaptor protein.
Schuster V; Kreth HW
Immunol Rev; 2000 Dec; 178():21-8. PubMed ID: 11213803
[TBL] [Abstract][Full Text] [Related]
18. [Genetic and proteinic analysis of a Chinese boy with X-linked lymphoproliferative disease and his maternal relatives].
Yang X; Wang J; An YF; Kanegane H; Miyawaki T; Zhao XD
Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):416-20. PubMed ID: 21924052
[TBL] [Abstract][Full Text] [Related]
19. Role of the 2B4 Receptor in CD8+ T-Cell-Dependent Immune Control of Epstein-Barr Virus Infection in Mice With Reconstituted Human Immune System Components.
Chijioke O; Marcenaro E; Moretta A; Capaul R; Münz C
J Infect Dis; 2015 Sep; 212(5):803-7. PubMed ID: 25722295
[TBL] [Abstract][Full Text] [Related]
20. Increased lymphocyte viability after non-stimulated peripheral blood mononuclear cell (PBMC) culture in patients with X-linked lymphoproliferative disease (XLP).
Belmonte L; Parodi C; Bastón M; Coraglia A; Felippo M; Baré P; Malbrán A; Ruibal-Ares B; de E de Bracco MM
Clin Immunol; 2009 Oct; 133(1):86-94. PubMed ID: 19576857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
